Table 4.

Insulin dose required by patients to maintain glycemic control in subjects between groups at the endpoint.

	CSII Group (n = 50)	MDI Group (n = 52)	P value
TOD (IU)	25.3 ± 5.0	32.3 ± 2.9	0.00
1000–2400 (IU)	21.6 ± 4.1	26.1 ± 2.4	0.00
0000–1000 (IU)	3.8 ± 1.2	6.2 ± 0.7	0.00
0000–1600 (IU)	12.2 ± 2.0	16.2 ± 1.5	0.00
1600–2000 (IU)	5.5 ± 1.4	7.4 ± 1.0	0.00
2000–2400 (IU)	3.8 ± 1.1	2.5 ± 0.3	0.00
TOD/Kg (IU/Kg)	0.4 ± 0.1	0.5 ± 0.1	0.00
1000–2400 (IU/Kg)	0.3 ± 0.1	0.4 ± 0.1	0.00
0000–1000 (IU/Kg)	0.1 ± 0.0	0.1 ± 0.0	0.00
1000–1600 (IU/Kg)	0.2 ± 0.0	0.3 ± 0.0	0.00
1600–2000 (IU/Kg)	0.1 ± 0.0	0.1 ± 0.0	0.00
2000–2400 (IU/Kg)	0.1 ± 0.0	0.0 ± 0.0	0.00

TOD: Total daily dose.